Login / Signup

Developing an in vitro model of haematoma for study of intracerebral haemorrhage.

Siobhan CrillyVictor Sebastian TapiaCarlo BawnAnnalisa Tirella
Published in: Biomaterials science (2024)
Intracerebral haemorrhage (ICH) is a devastating neurovascular attack with limited treatment options. Alternative, pre-clinical modelling approaches are required to identify and trial therapeutic drug compounds. In this study we have used alginate hydrogels to model blood insult in vitro . Human whole blood was mixed with alginate and encapsulated into hydrogel beads. Beads were then incorporated in a second layer of alginate containing hyaluronic acid/chitosan nanoparticles to mimic the mechanical properties of brain tissue and create a model haematoma. Beads and model haematomas were characterised to profile size, volume, mechanical properties, release capacity and storage stability over time. Beads and model haematomas stimulate a pro-inflammatory phenotype in human monocytic and macrophage-like cells, however have no pathogenic effect on brain endothelial and neuronal cell survival or function. In conclusion, we have developed an effective strategy to model ICH in vitro , to investigate the human immune response to blood insult.
Keyphrases
  • hyaluronic acid
  • endothelial cells
  • drug delivery
  • clinical trial
  • tissue engineering
  • cerebral ischemia
  • blood brain barrier
  • phase ii
  • drug release